Boston Scientific Beats Its Own Fourth-Quarter Guidance On Cardiovascular Strength
Boston Scientific stock dipped Wednesday, but the medtech company beat Wall Street's fourth-quarter forecasts. The post Boston Scientific Beats Its Own Fourth-Quarter Guidance On Cardiovascular Strength appeared first on Investor's Business Daily.
Boston Scientific stock dipped Wednesday, but the medtech company beat Wall Street's fourth-quarter forecasts.
The post Boston Scientific Beats Its Own Fourth-Quarter Guidance On Cardiovascular Strength appeared first on Investor's Business Daily.